Retrospective Study
Copyright ©The Author(s) 2020.
World J Clin Cases. Jan 6, 2020; 8(1): 20-28
Published online Jan 6, 2020. doi: 10.12998/wjcc.v8.i1.20
Table 1 Baseline characteristics in both groups, n (%)
Before propensity matching
After propensity matching
Beginner (n = 97)Expert (n = 196)P valueDBeginner (n = 69)Expert (n = 69)P valueD
Female35 (36.1)104 (53.1)0.0060.38318 (26.1)10 (14.5)0.0900.404
Age69.8 ± 12.267.6± 12.30.1430.17971.8 ± 11.072.2 ± 10.70.7900.037
Angle29.5 ± 15.530.1 ± 16.10.7520.03829.6 ± 15.930.3 ± 16.40.7890.043
Angle > 30 (%)45 (46.4)96 (49.0)0.6780.05732 (46.4)33 (47.8)0.8650.032
Bile duct dilatation9.0 ± 3.38.2 ± 3.40.0460.2389.4 ± 3.310.0 ± 4.00.3220.164
Benign Dz78 (80.4)132 (67.3)0.0190.38063 (91.3)64 (92.8)0.7530.109
Peripheral arterial disease30 (30.9)67 (34.2)0.5790.08224 (34.8)32 (46.4)0.1650.267
Erythema10 (10.3)26 (13.3)0.4700.1588 (11.6)11 (15.9)0.4590.203
Bulging5 (5.2)12 (6.1)0.7400.1012 (2.9)7 (10.1)0.0850.733
Table 2 Result of endoscopic retrograde cholangiopancreatography between acute or obtuse angle in both group, n (%)
Beginner endoscopist
Expert endoscopist
Total (n = 69)Acute angle (n = 37)Obtuse angle (n = 32)P valueTotal (n = 69)Acute angle (n = 36)Obtuse angle (n = 33)P value
Success rate67 (97.1)35 (94.6)32 (100)0.18768 (98.6)36 (100)32 (97)0.293
Cannulation time5.5 ± 6.06.7 ± 7.24.1 ± 4.20.0764.3 ± 2.94.2 ± 2.94.3 ± 2.90.833
Total procedure19.6 ± 10.320.7 ± 11.218.3 ± 9.20.33017.7 ± 7.516.8 ± 4.418.8 ± 9.90.296
P-duct insertion or injection22 (31.9)14 (37.8)8 (25.0)0.26010 (17.4)6 (22.2)4 (12.1)0.276
P-duct stent19 (27.5)12 (32.4)7 (21.9)0.3357 (10.1)4 (11.1)3 (9.1)0.785
PEP9 (13.0)8 (21.6)1 (3.1)0.023a3 (4.3)1 (2.8)2 (6.1)0.511
Hyperamylase-mia12 (17.4)6 (16.2)6 (18.8)0.78612 (17.4)6 (16.7)6 (18.2)0.868
Bleeding2 (2.9)1 (2.7)1 (3.1)0.9181 (1.4)0 (0)1 (3.0)0.293
Perforation0 (0)0 (0)0 (0)N/A0 (0)0 (0)0 (0)N/A
Table 3 Clinical factors associated with post-endoscopic retrograde cholangiopancreatography pancreatitis in beginner group, n (%)
Beginner endoscopist
Total (n = 69)With PEP (n = 9)Without PEP (n = 60)P value
UnivariableMultivari-able
Age (yr)71.8 ± 11.073.0 ± 6.571.6 ± 11.50.718-
Female18 (26.1)4 (44.4)14 (23.3)0.1840.182
Periampullary diverticulum24 (34.8)3 (33.3)21 (35.0)0.923-
Erythema8 (11.6)1 (1.1)7 (11.7)0.865-
Buldging2 (2.9)0 (0.0)2 (3.3)0.585-
Malignancy6 (8.7)0 (0)6 (10.0)0.328-
Benign diseases63 (91.3)9 (100)54 (90.0)--
Bile duct dilatation9.4 ± 3.39.4 ± 4.49.4 ± 3.20.937-
Acute angle37 (53.6)8 (88.9)29 (48.3)0.023a0.049a
Cannulation time (min)5.5 ± 6.06.8 ± 2.15.3 ± 6.40.534-
Total Procedure time (min)19.6 ± 10.317.3 ± 4.919.9 ± 10.90.492-
P-duct insertion or injection22 (31.9)5 (55.6)17 (28.3)0.1050.181
P-duct stent19 (27.5)3 (33.3)16 (26.7)0.682-
Table 4 Clinical factors associated with post-endoscopic retrograde cholangiopancreatography pancreatitis in all patients, n (%)
Total (n = 138)With PEP (n = 12)Without PEP (n = 126)P value
UnivariableMultivariable
Age (yr)72.0 ± 10.872.1 ± 7.072.0 ± 11.10.978-
Female28 (20.3)5 (41.7)23 (18.3)0.0550.017a
Periampullary diverticulum56 (40.6)3 (25.0)53 (42.1)0.253-
Erythema19 (13.8)2 (16.7)17 (13.5)0.762-
Buldging9 (6.5)0 (0.0)9 (7.1)0.342-
Malignancy11 (8.7)0 (0)11 (8.7)0.289-
Benign diseases127 (92.0)12 (100)115 (91.3)--
Bile duct dilatation9.7 ± 3.79.8 ± 3.99.7 ± 3.70.941-
Acute angle73 (52.9)9 (75.0)64 (50.8)0.1100.324
Beginner endoscopist69 (50.0)9 (75.0)60 (47.6)0.0710.743
Cannulation time (min)5.0 ± 4.76.7 ± 2.24.8 ± 4.90.2010.052
Total Procedure time (min)18.7 ± 9.116.8 ± 4.918.8 ± 9.40.467-
P-duct insertion or injection32 (23.2)7 (58.3)25 (19.8)0.002a0.003a
P-duct stent27 (19.6)3 (25.0)24 (19.0)0.622-